Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

MedTech specialist joins Research Partnership

June 21, 2022 | Medtech 

Janet Powers has joined the company as a Director in the MedTech division.

We are delighted to announce that Janet Powers has joined the company as a Director in the MedTech division. Based in the US, Janet has worked in healthcare her entire career and has over 21 years of experience in research and consulting. She brings strong MedTech experience to the team having worked with most of the top 25 firms in the industry.

Janet most recently served as Senior Vice President of Research at MedPanel overseeing all qualitative and quantitative projects, recruitment and panel development. Other previous roles include Director of Business Intelligence at Philips Healthcare and Vice President of Analysis at Eliza Corporation.

Head of the MedTech Division, Sabera Hyderally said of her appointment, “I am delighted to welcome Janet to the MedTech Division. She brings a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with a researcher of her calibre as we continue our tremendous growth globally.”

Speaking about the appointment, Co-CEO Mary Assimakopoulos said, “We are very pleased that Janet has chosen to join Research Partnership. She has previously worked with a range of MedTech clients and brings a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”

Visit researchpartnership.com to find out more.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...